1. POSITION’S ASSIGNMENT
As a cosmetic safety assessor, you will be responsible for planning and conducting cosmetic safety assessment of raw materials as well as finished products intended to be developed in China. You will plan and perform assessment tasks like preclinical and clinical tests (in compliance with the internal guidelines and safety standards). You will compile an assessment report that documents the results of your work in line with the local cosmetic product safety regulation and other relevant legislation and standards in the cosmetics and hygiene area.
2. KEY ACCOUNTABILITIES
1. Safety assessment: provide safety assessment on raw materials, cosmetic ingredients, substances and impurities as well as finished product developed in China, according to the SCCS guidelines (last version) and applicable safety standards. Work closely with our Scientific Evaluation Department to provide a full service.
2. Testing: identify and plan preclinical and clinical studies to support the safety of the products. Plan your work according to the project’s milestones.
3. Safety audit: performs safety audit with CRO, generate audit reports and follow up audit findings in collaboration with the QA department.
4. Management and development of clinical protocols for new development
5. Provide technical support to Asian clinical studies regarding the development, implementation, monitoring and control (times and costs), aligned with the goals and strategic plan of the brands and in accordance with the recommendations and requirements of PFDC;
6. Development of new and innovative methodologies to support the valorization of portfolio products and new developments
7. Development of screenings and internal panels to assist the formulation team during the development of new products;
8. Provide technical and scientific support to ensure brand awareness/institutional image through the relationship with different customers: dermatologists and consumers, linked to PFDC Brazil's internal services, such as customer service and cosmetovigilance.
9. Interface with CROs for the development of in vivo and in vitro studies
10. Interface with local and international marketing departments
11. Interface with international departments (Pharmacology, Clinical, Toxicology)
